The Role of Visceral Hypersensitivity in Irritable Bowel Syndrome: Pharmacological Targets and Novel Treatments

Irritable bowel syndrome (IBS) is the most common disorder referred to gastroenterologists and is characterized by altered bowel habits, abdominal pain, and bloating. Visceral hypersensitivity (VH) is a multifactorial process that may occur within the peripheral or central nervous systems and plays a principal role in the etiology of IBS symptoms. The pharmacological studies on selective drugs based on targeting specific ligands can provide novel therapies for modulation of persistent visceral hyperalgesia. The current paper reviews the cellular and molecular mechanisms underlying therapeutic targeting for providing future drugs to protect or treat visceroperception and pain sensitization in IBS patients. There are a wide range of mediators and receptors participating in visceral pain perception amongst which substances targeting afferent receptors are attractive sources of novel drugs. Novel therapeutic targets for the management of VH include compounds which alter gut-brain pathways and local neuroimmune pathways. Molecular mediators and receptors participating in pain perception and visceroperception include histamine-1 receptors, serotonin (5-hydrodytryptamine) receptors, transient receptor potential vanilloid type I, tachykinins ligands, opioid receptors, voltage-gated channels, tyrosine receptor kinase receptors, protease-activated receptors, adrenergic system ligands, cannabinoid receptors, sex hormones, and glutamate receptors which are discussed in the current review. Moreover, several plant-derived natural compounds with potential to alleviate VH in IBS have been highlighted. VH has an important role in the pathology and severity of complications in IBS. Therefore, managing VH can remarkably modulate the symptoms of IBS. More preclinical and clinical investigations are needed to provide efficacious and targeted medicines for the management of VH.

• Publication year

  2016

• Venue

  Journal of Neurogastroenterology and Motility

• Publication date

  2016-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.5056/jnm16001PMID 27431236PMCID 5056566
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A Systematic Review of Plant-Derived Natural Compounds for Anxiety Disorders.

  2016cited by this paper
• Prevalence of Irritable Bowel Syndrome in Singapore and Its Association with Dietary, Lifestyle, and Environmental Factors

  2016cited by this paper
• Protease-activated receptor 2 activation is sufficient to induce the transition to a chronic pain state

  2015cited by this paper
• Identification of a highly potent and selective CB2 agonist, RQ-00202730, for the treatment of irritable bowel syndrome.

  2015cited by this paper
• Phytochemical constituents as future antidepressants: a comprehensive review

  2015cited by this paper
• Role of dietary polyphenols in the management of peptic ulcer.

  2015cited by this paper
• The role of dietary polyphenols in the management of inflammatory bowel disease.

  2015cited by this paper
• A Global Perspective

  2015cited by this paper
• Irritable bowel syndrome: emerging paradigm in pathophysiology.

  2014cited by this paper
• The effect of curcumin on the brain-gut axis in rat model of irritable bowel syndrome: involvement of 5-HT-dependent signaling

  2014cited by this paper
• Curcumin Reverse Methicillin Resistance in Staphylococcus aureus

  2014cited by this paper
• Pharmacokinetic Comparison of Berberine in Rat Plasma after Oral Administration of Berberine Hydrochloride in Normal and Post Inflammation Irritable Bowel Syndrome Rats

  2014cited by this paper
• Markers for visceral hypersensitivity in patients with irritable bowel syndrome

  2014cited by this paper
• Randomised clinical trial: a liquid multi‐strain probiotic vs. placebo in the irritable bowel syndrome – a 12 week double‐blind study

  2014cited by this paper
• Multispecies probiotic protects gut barrier function in experimental models.

  2014influential reference
• Irritable bowel syndrome: pathogenesis, diagnosis, treatment, and evidence-based medicine.

  2014cited by this paper
• Toll-like receptor 4 regulates chronic stress-induced visceral pain in mice.

  2014cited by this paper
• NMDA and AMPA receptors in the anterior cingulate cortex mediates visceral pain in visceral hypersensitivity rats.

  2014cited by this paper
• Review article: the economic impact of the irritable bowel syndrome

  2014cited by this paper
• The Impact of Physical Complaints, Social Environment, and Psychological Functioning on IBS Patients’ Health Perceptions: Looking Beyond GI Symptom Severity

  2014cited by this paper
• Acupuncture-moxibustion in treating irritable bowel syndrome: how does it work?

  2014influential reference
• Neuron-glial communication mediated by TNF-α and glial activation in dorsal root ganglia in visceral inflammatory hypersensitivity.

  2014cited by this paper
• TRPV1 receptor inhibition decreases CCL2-induced hyperalgesia.

  2014cited by this paper
• Adrenergic β2-Receptors Mediates Visceral Hypersensitivity Induced by Heterotypic Intermittent Stress in Rats

  2014cited by this paper
• Are There Any Different Effects of Bifidobacterium, Lactobacillus and Streptococcus on Intestinal Sensation, Barrier Function and Intestinal Immunity in PI-IBS Mouse Model?

  2014cited by this paper
• Serotonin receptors and their role in the pathophysiology and therapy of irritable bowel syndrome

  2014cited by this paper
• Mucosal Mast Cell Count Is Associated With Intestinal Permeability in Patients With Diarrhea Predominant Irritable Bowel Syndrome

  2013cited by this paper
• Antinociceptive effect of berberine on visceral hypersensitivity in rats.

  2013cited by this paper
• Protease-activated receptors as therapeutic targets in visceral pain.

  2013cited by this paper
• Panax ginseng in Randomised Controlled Trials: A Systematic Review

  2013cited by this paper
• Stress-Induced Visceral Hypersensitivity in Maternally Separated Rats Can Be Reversed by Peripherally Restricted Histamine-1-Receptor Antagonists

  2013influential reference
• Patients With Irritable Bowel Syndrome With Diarrhea in a Phase 2 Study

  2013cited by this paper
• Probiotics VSL#3 Protect against Development of Visceral Pain in Murine Model of Irritable Bowel Syndrome

  2013cited by this paper
• Plant Derived Aporphinic Alkaloid S-(+)-Dicentrine Induces Antinociceptive Effect in Both Acute and Chronic Inflammatory Pain Models: Evidence for a Role of TRPA1 Channels

  2013cited by this paper
• Efficacy and mode of action of mesalazine in the treatment of diarrhoea-predominant irritable bowel syndrome (IBS-D): study protocol for a randomised controlled trial

  2013cited by this paper
• Curcumin acts via transient receptor potential vanilloid‐1 receptors to inhibit gut nociception and reverses visceral hyperalgesia

  2013cited by this paper
• l-Tetrahydropalmatine, an Active Component of Corydalis yanhusuo W.T. Wang, Protects against Myocardial Ischaemia-Reperfusion Injury in Rats

  2012cited by this paper
• Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis.

  2012cited by this paper
• An Update on Post-infectious Irritable Bowel Syndrome: Role of Genetics, Immune Activation, Serotonin and Altered Microbiome

  2012cited by this paper
• Synthesis and Biological Evaluation of Berberine Derivatives as IBS Modulator

  2012cited by this paper
• G Protein-Coupled Receptor Kinase 6 Acts as a Critical Regulator of Cytokine-Induced Hyperalgesia by Promoting Phosphatidylinositol 3-Kinase and Inhibiting p38 Signaling

  2012cited by this paper
• Review article: associations between immune activation, intestinal permeability and the irritable bowel syndrome

  2012cited by this paper
• Rectal hypersensitivity as hallmark for irritable bowel syndrome: defining the optimal cutoff

  2012influential reference
• Activation of colonic mucosal 5-HT(4) receptors accelerates propulsive motility and inhibits visceral hypersensitivity.

  2012cited by this paper
• Costs of irritable bowel syndrome in the UK and US

  2012cited by this paper
• Herbal medicines for the management of irritable bowel syndrome: a comprehensive review.

  2012cited by this paper
• Revisiting concepts of visceral nociception in irritable bowel syndrome

  2012cited by this paper
• Effect of Gender on Prevalence of Irritable Bowel Syndrome in the Community: Systematic Review and Meta-Analysis

  2012cited by this paper
• Antinociceptive Effects of a Chloroform Extract and the Alkaloid Dicentrine Isolated from Fruits of Ocotea puberula

  2012cited by this paper
• Health benefits and health claims of probiotics: bridging science and marketing

  2011cited by this paper
• Mechanisms Underlying Visceral Hypersensitivity in Irritable Bowel Syndrome

  2011cited by this paper
• Intestinal Serotonin Release, Sensory Neuron Activation, and Abdominal Pain in Irritable Bowel Syndrome

  2011cited by this paper
• Management of irritable bowel syndrome (IBS) in adults: conventional and complementary/alternative approaches.

  2011cited by this paper
• T-type calcium channels contribute to colonic hypersensitivity in a rat model of irritable bowel syndrome

  2011cited by this paper
• Antinociceptive effects of intragastric DL-tetrahydropalmatine on visceral and somatic persistent nociception and pain hypersensitivity in rats.

  2011cited by this paper
• Altered peripheral toll‐like receptor responses in the irritable bowel syndrome

  2011influential reference
• Influence of tegaserod on proximal gastric tone and on the perception of gastric distention in functional dyspepsia

  2011cited by this paper
• Angiostatic effects of K252a, a Trk inhibitor, in murine brain capillary endothelial cells

  2010cited by this paper
• Genetic risk factors for post-infectious irritable bowel syndrome following a waterborne outbreak of gastroenteritis.

  2010influential reference
• Adrenergic stimulation mediates visceral hypersensitivity to colorectal distension following heterotypic chronic stress.

  2010cited by this paper
• Colitis elicits differential changes in the expression levels of receptor tyrosine kinase TrkA and TrkB in colonic afferent neurons: A possible involvement of axonal transport

  2010cited by this paper
• NMDA and AMPA receptors contribute to the maintenance of substance P-induced thermal hyperalgesia.

  2010cited by this paper
• Dysfunctional Cognitions, Anxiety and Depression in Irritable Bowel Syndrome

  2010cited by this paper
• Complementary and alternative medicine modalities for the treatment of irritable bowel syndrome: facts or myths?

  2010cited by this paper
• Analgesic effects of JCM-16021 on neonatal maternal separation-induced visceral pain in rats.

  2010cited by this paper
• The mast cell stabiliser ketotifen decreases visceral hypersensitivity and improves intestinal symptoms in patients with irritable bowel syndrome

  2010influential reference
• Protease‐activated receptor‐4 (PAR4): a role as inhibitor of visceral pain and hypersensitivity

  2009cited by this paper
• Complementary and alternative medicine for treatment of irritable bowel syndrome.

  2009cited by this paper
• Efficacy of probiotics in irritable bowel syndrome: a meta-analysis of randomized, controlled trials.

  2009cited by this paper
• The genetic basis of congenital hyperinsulinism

  2009cited by this paper
• Efficacy of tricyclic antidepressants in irritable bowel syndrome: a meta-analysis.

  2009cited by this paper
• Infection, inflammation, and the irritable bowel syndrome.

  2009cited by this paper
• High K+-induced contraction requires depolarization-induced Ca2+ release from internal stores in rat gut smooth muscle

  2009cited by this paper
• Review article: visceral hypersensitivity in irritable bowel syndrome: molecular mechanisms and therapeutic agents

  2009cited by this paper
• Bacillus coagulans significantly improved abdominal pain and bloating in patients with IBS.

  2009cited by this paper
• Effect of mesalazine on mucosal immune biomarkers in irritable bowel syndrome: a randomized controlled proof‐of‐concept study

  2009cited by this paper
• Epidemiology of irritable bowel syndrome in Asia: Something old, something new, something borrowed

  2009cited by this paper
• Contributions of Pain Sensitivity and Colonic Motility to IBS Symptom Severity and Predominant Bowel Habits

  2008cited by this paper
• Pharmacological evaluation of a novel cannabinoid 2 (CB2) ligand, PF-03550096, in vitro and in vivo by using a rat model of visceral hypersensitivity.

  2008cited by this paper
• Role for NMDA receptors in visceral nociceptive transmission in the anterior cingulate cortex of viscerally hypersensitive rats.

  2008cited by this paper
• The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review

  2008cited by this paper
• First evidence for an association of a functional variant in the microRNA-510 target site of the serotonin receptor-type 3E gene with diarrhea predominant irritable bowel syndrome.

  2008cited by this paper
• Clinical trial: asimadoline in the treatment of patients with irritable bowel syndrome

  2008cited by this paper
• Symptom severity but not psychopathology predicts visceral hypersensitivity in irritable bowel syndrome.

  2008cited by this paper
• Comparison of the antidiabetic activity of Berberis lyceum root extract and berberine in alloxan‐induced diabetic rats

  2008cited by this paper
• Selective serotonin reuptake inhibitors for the management of irritable bowel syndrome: a meta-analysis of randomized controlled trials

  2008cited by this paper
• A-803467, a potent and selective Nav1.8 sodium channel blocker, attenuates neuropathic and inflammatory pain in the rat

  2008cited by this paper
• Efficacy of Probiotics in Irritable Bowel Syndrome: A Meta-Analysis of Randomized, Controlled Trials

  2008cited by this paper
• Increased capsaicin receptor TRPV1-expressing sensory fibres in irritable bowel syndrome and their correlation with abdominal pain

  2008cited by this paper
• Mast cell-dependent excitation of visceral-nociceptive sensory neurons in irritable bowel syndrome.

  2007cited by this paper
• Importance of 5‐hydroxytryptamine receptors on intestinal afferents in the regulation of visceral sensitivity

  2007cited by this paper
• Altered rectal perception in irritable bowel syndrome is associated with symptom severity.

  2007cited by this paper
• Peripheral and central mechanisms of visceral sensitization in man

  2007cited by this paper
• The vanilloid receptor initiates and maintains colonic hypersensitivity induced by neonatal colon irritation in rats.

  2007cited by this paper
• Curcumin: the Indian solid gold.

  2007cited by this paper
• FUNCTIONAL BOWEL DISORDERS

  2007cited by this paper
• A-803467, a potent and selective Nav1.8 sodium channel blocker, attenuates neuropathic and inflammatory pain in the rat

  2007cited by this paper
• Estrogen rapidly modulates mustard oil-induced visceral hypersensitivity in conscious female rats: A role of CREB phosphorylation in spinal dorsal horn neurons.

  2007cited by this paper
• Effect of the NK3 receptor antagonist, talnetant, on rectal sensory function and compliance in healthy humans

  2007cited by this paper
• The vanilloid receptor TRPV1: 10 years from channel cloning to antagonist proof-of-concept

  2007cited by this paper

• Dose‐Dependent Effect of the Histamine 1 Receptor Antagonist Ebastine in Patients With Non‐Constipated Irritable Bowel Syndrome

  2026cites this paper
• Female Sexual Dysfunction and Irritable Bowel Syndrome: A Cross-Sectional Study in Jordanian Women

  2026cites this paper
• Revisiting Abdominal Pain in IBS: From Pathophysiology to Targeted Management with Alverine Citrate/Simeticone

  2026influential citation
• Gut microbiota in irritable bowel syndrome: a narrative review of mechanisms and microbiome-based therapies

  2025cites this paper
• Changji’an formula alleviates visceral hypersensitivity of a post-inflammatory IBS-D mouse model via NGF/TrkA signaling pathway

  2025cites this paper
• Current Diagnosis and Treatment of Irritable Bowel Syndrome

  2025cites this paper
• Current Landscape of Novel Therapeutic Agents and Drug Targets in Irritable Bowel Syndrome

  2025cites this paper
• Increased Allergic Rhinitis Prevalence and Symptom Severity in Patients With Irritable Bowel Syndrome

  2025cites this paper
• Electroacupuncture at Baliao Points Attenuates Visceral Hypersensitivity in Irritable Bowel Syndrome via Gut‐Microbiota‐Mast Cell‐TPRV1 Axis Modulation

  2025cites this paper
• Could the Therapeutic Effect of Physical Activity on Irritable Bowel Syndrome Be Mediated Through Changes to the Gut Microbiome? A Narrative and Hypothesis Generating Review

  2025cites this paper
• Targeting TRPV1: a potential strategy for traditional Chinese medicine to combat diarrhea predominant irritable bowel syndrome

  2025cites this paper
• Comparative Analysis of Gut Microbiota in Patients with Irritable Bowel Syndrome and Healthy Controls

  2025cites this paper
• The long road to diagnosis, from gastroesophageal reflux disease, through Barrett's esophagus, to visceral hypersensitivity: a case report

  2025cites this paper
• Natural Remedies for Irritable Bowel Syndrome: A Comprehensive Review of Herbal-Based Therapies

  2025cites this paper
• Predicting response to the low FODMAP diet in irritable bowel syndrome: Current evidence and clinical considerations.

  2025cites this paper
• Decoding Abdominal Pain in Constipation-predominant Irritable Bowel Syndrome and Functional Constipation: Mechanisms and Managements

  2025cites this paper
• Regulatory Roles of Noncoding RNAs in Visceral Hypersensitivity in Irritable Bowel Syndrome

  2025cites this paper
• The Role of Colonic Microbiota in Constipation Predominant Irritable Bowel Syndrome: A Literature Review.

  2025cites this paper
• Host Transcriptome and Microbial Variation in Relation to Visceral Hyperalgesia

  2025cites this paper
• Role of KV and BK Channels in the Effects of Sodium Butyrate on Colon Motility in a Mouse Model of Irritable Bowel Syndrome

  2025cites this paper
• The Features of Neural Mechanisms Underlying Visceral Pain Processing in the Basolateral Amygdala of Rats with Post-Inflammatory or Stress-Induced Hyperalgesia

  2025cites this paper
• Effects of Hydrogen Sulfide and Nitric Oxide on Rat Jejunum Contractions in a Model of Irritable Bowel Syndrome

  2025cites this paper
• Gastrointestinal-specific anxiety as a transdiagnostic mechanism involved in persons with irritable bowel syndrome who smoke

  2025cites this paper
• Characterisation of MRGPRX2+ mast cells in irritable bowel syndrome

  2025cites this paper
• Gastrointestinal-specific anxiety and smoking abstinence expectancies among persons with irritable bowel syndrome

  2025cites this paper
• Therapeutic Potential of Short-Chain Fatty Acids in Gastrointestinal Diseases

  2025cites this paper
• Regulation of the hippocampal TRPV1 pathway by umbilical therapy to alleviate visceral hypersensitivity in rats with diarrhea-predominant irritable bowel syndrome

  2025cites this paper
• Healthcare Utilization and Costs of Care in Patients With Irritable Bowel Syndrome With Constipation or Chronic Idiopathic Constipation After Initiating Oral Therapies: Real-World Analysis in the US Medicare Population

  2025cites this paper
• Gut–Brain–Microbiota Axis in Irritable Bowel Syndrome: A Narrative Review of Pathophysiology and Current Approaches

  2025cites this paper
• Microbiota–neuroepithelial signalling across the gut–brain axis

  2025cites this paper
• Effects of a low-FODMAP diet on patients with endometriosis, a prospective cohort study

  2025cites this paper
• Prevalence and Predictors of Symptoms of Anxiety or Depression at Diagnosis in Patients With Inflammatory Bowel Disease: An Inception Cohort

  2025cites this paper
• Patient-Provider Communication: The Key to Improving IBS-C Management.

  2025cites this paper
• Raising Expectations in IBS-C Management.

  2025cites this paper
• Low-FODMAP diet and hidradenitis suppurativa: the role of nutritionists in the management of dermato-endocrine disorders.

  2024cites this paper
• An Overview of the Effects of Tenapanor on Visceral Hypersensitivity in the Treatment of Irritable Bowel Syndrome with Constipation

  2024cites this paper
• The Possible Synergistic Pharmacological Effect of an Oral Berberine (BBR) and Curcumin (CUR) Complementary Therapy Alleviates Symptoms of Irritable Bowel Syndrome (IBS): Results from a Real-Life, Routine Clinical Practice Settings-Based Study

  2024cites this paper
• Systematic Review on Herbal Preparations for Controlling Visceral Hypersensitivity in Functional Gastrointestinal Disorders.

  2024cites this paper
• Continuing the Dialogue in IBS-C Management: Importance of Individualizing Care and Tailoring Treatment.

  2024cites this paper
• Abdominal Symptom Improvement During Clinical Trials of Tenapanor in Patients With Irritable Bowel Syndrome With Constipation: A Post Hoc Analysis

  2024cites this paper
• Whole Gut Motility Patterns in Patients with Chronic Nausea and Vomiting

  2024cites this paper
• The Latest Data Concerning the Etiology and Pathogenesis of Irritable Bowel Syndrome

  2024influential citation
• Morphological Changes of the Pituitary Gland in Patients with Irritable Bowel Syndrome Using Magnetic Resonance Imaging

  2024cites this paper
• Clinical response to Rifaximin amongst irritable bowel syndrome (IBS) patients at tertiary level hospital in Nepal

  2024cites this paper
• Animal models with characteristics of irritable bowel syndrome with diarrhea: current applications and future perspectives.

  2024cites this paper
• Effect of thymoquinone on acetic acid-induced visceral nociception in rats: role of central cannabinoid and α2-adrenergic receptors

  2024cites this paper
• Review of the Patient Burden and Therapeutic Landscape of Irritable Bowel Syndrome with Constipation in the United States

  2024cites this paper
• Tenapanor Improves Abdominal Symptoms Irrespective of Changes in Complete Spontaneous Bowel Movement Frequency in Adults with Irritable Bowel Syndrome with Constipation

  2024cites this paper
• Nitric oxide in the mechanisms of inhibitory effects of sodium butyrate on colon contractions in a mouse model of irritable bowel syndrome

  2024cites this paper
• Network pharmacology and experimental validation to explore the mechanism of Changji'an formula against irritable bowel syndrome with predominant diarrhea

  2024cites this paper
• Raising the Bar in the Management of IBS-C.

  2023cites this paper
• Opposing effects of 5‐HT1A receptor agonist buspirone on supraspinal abdominal pain transmission in normal and visceral hypersensitive rats

  2023cites this paper
• The place of antispasmodic drugs in modern therapy of irritable bowel syndrome

  2023cites this paper
• Evaluation of the Impact of Some Single-Nucleotide Gene Polymorphisms on the Development of Adenomatous Polyps of the Colon in Patients with Irritable Bowel Syndrome

  2023cites this paper
• Cytolethal distending toxin B inoculation leads to distinct gut microtypes and IBS-D-like microRNA-mediated gene expression changes in a rodent model

  2023cites this paper
• Macrophages in intestinal homeostasis and inflammatory bowel disease

  2023cites this paper
• The Intersection of Disorders of Gut-Brain Interaction With Avoidant/Restrictive Food Intake Disorder

  2023cites this paper
• The influence of Nav1.9 channels on intestinal hyperpathia and dysmotility

  2023cites this paper
• Gut–Brain Axis, Microbiota and Probiotics—Current Knowledge on Their Role in Irritable Bowel Syndrome: A Review

  2023cites this paper
• APETx2 regulates intestinal motility and visceral sensitivity in post-infectious irritable bowel syndrome mice through 5-HT signalling pathway.

  2023cites this paper
• Pharmacotherapy for gastric and intestinal cramping pain: ‎ current and emerging therapies

  2023cites this paper
• Metabotropic glutamate receptor-8 relieves neonatal maternal separation-induced visceral hypersensitivity in rats by regulating expression of TNF-α

  2023cites this paper
• The Importance of Visceral Hypersensitivity in Irritable Bowel Syndrome—Plant Metabolites in IBS Treatment

  2023cites this paper
• Understanding the Current Approaches in the Management of IBS-C: A Case Study.

  2023cites this paper
• Best Parameters of Heart Rate Variability for Assessing Autonomic Responses to Brief Rectal Distention in Patients with Irritable Bowel Syndrome

  2023cites this paper
• Translation and validation of the Ukrainian version of the visceral sensitivity index for patients with irritable bowel syndrome

  2023cites this paper
• [Long-term probiotic administration for irritable bowel syndrome: a legal need].

  2023cites this paper
• Ethanol Extract of Mao Jian Green Tea Attenuates Gastrointestinal Symptoms in a Rat Model of Irritable Bowel Syndrome with Constipation via the 5-hydroxytryptamine Signaling Pathway

  2023cites this paper
• MicroRNA-based therapeutics for inflammatory disorders of the microbiota-gut-brain axis.

  2023cites this paper
• Postcolitis Alterations in Nociceptive Properties of Neurons in the Rat Nucleus Raphe Magnus and Dorsal Raphe Nucleus

  2023cites this paper
• Lactococcus lactis CNCM I‐5388 versus NCDO2118 by its GABA hyperproduction ability, counteracts faster stress‐induced intestinal hypersensitivity in rats

  2023cites this paper
• POSTСOLITIS ALTERATIONS IN NOCICEPTIVE PROPERTIES OF NEURONS IN THE RAT RAPHE MAGNUS AND DORSAL RAPHE NUCLEI

  2023cites this paper
• Gut microbiota modulates visceral sensitivity through calcitonin gene-related peptide (CGRP) production

  2023cites this paper
• Functional Implications and Clinical Potential of MicroRNAs in Irritable Bowel Syndrome: A Concise Review

  2022cites this paper
• Sex differences in pain-related behaviors and clinical progression of disease in mouse models of colonic pain

  2022cites this paper
• Antibiotics, gut microbiota, and irritable bowel syndrome: What are the relations?

  2022cites this paper
• Effects of FODMAPs and gluten on irritable bowel syndrome- from self-reported symptoms to molecular profiling

  2022cites this paper
• Inhibition of Serine Proteases as a Novel Therapeutic Strategy for Abdominal Pain in IBS

  2022cites this paper
• Pathophysiological Commonality Between Irritable Bowel Syndrome and Metabolic Syndrome: Role of Corticotropin-releasing Factor–Toll-like Receptor 4–Proinflammatory Cytokine Signaling

  2022cites this paper
• Pain relief and pain intensity response to GLP-1 receptor agonist ROSE-010 in irritable bowel syndrome; clinical study cross-analysis with respect to patient characteristics

  2022cites this paper
• Efficacy of a Product Containing Xyloglucan and Pea Protein on Intestinal Barrier Function in a Partial Restraint Stress Animal Model

  2022cites this paper
• Children And Adolescents With Irritable Bowel Syndrome: Treatment And Management.

  2022cites this paper
• Paeoniflorin alleviates inflammatory response in IBS-D mouse model via downregulation of the NLRP3 inflammasome pathway with involvement of miR-29a

  2022cites this paper
• Burden of Constipation: Looking Beyond Bowel Movements

  2022cites this paper
• [Visceral sensitivity in diagnostics and treatment of severe irritated bowel syndrome].

  2022cites this paper
• Psychosocial and Sensory Factors Contribute to Self-Reported Pain and Quality of Life in Young Adults with Irritable Bowel Syndrome.

  2022cites this paper
• Regional brain activation during rectal distention and attenuation with alosetron in a nonhuman primate model of irritable bowel syndrome

  2022cites this paper
• Diet and irritable bowel syndrome: an update from a UK consensus meeting

  2022cites this paper
• YINDARA-4 relieves visceral hypersensitivity in irritable bowel syndrome rats via regulation of gut microbiota and serotonin levels

  2022cites this paper
• Current Treatment Options and Therapeutic Insights for Gastrointestinal Dysmotility and Functional Gastrointestinal Disorders

  2022cites this paper
• Enterochromaffin Cells–Gut Microbiota Crosstalk: Underpinning the Symptoms, Pathogenesis, and Pharmacotherapy in Disorders of Gut-Brain Interaction

  2022cites this paper
• Diagnosis and management of irritable bowel syndrome-like symptoms in ulcerative colitis.

  2022influential citation
• Mechanism of the Treatment of Irritable Bowel Syndrome with Sini Powder and Tong Xie Yao Fang Decoction Based on Network Pharmacology

  2022cites this paper
• Involvement of toll-like receptor 5 in mouse model of colonic hypersensitivity induced by neonatal maternal separation

  2022cites this paper
• Clinical assessment and cytokines level in constipation-predominant irritable bowel syndrome participants treated with Lactobacillus-containing cultured milk drink.

  2021cites this paper
• Altered metabolome and microbiome features provide clues in understanding irritable bowel syndrome and depression comorbidity

  2021cites this paper
• Volumetric Rectal Perception Testing: Is It Clinically Relevant? Results From a Large Patient Cohort

  2021cites this paper
• The neglected role of Blastocystis sp. and Giardia lamblia in development of irritable bowel syndrome: A systematic review and meta-analysis.

  2021cites this paper
• Caffeine and mitochondria with a focus on the central nervous system

  2021cites this paper
• Review article: current and future treatment approaches for pain in IBS

  2021cites this paper